Terns Pharmaceuticals Stock Forecast - Triple Exponential Smoothing
| TERN Stock | USD 39.19 0.92 2.29% |
The Triple Exponential Smoothing forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 39.43 with a mean absolute deviation of 1.14 and the sum of the absolute errors of 68.15. Terns Stock Forecast is based on your current time horizon. Although Terns Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Terns Pharmaceuticals' systematic risk associated with finding meaningful patterns of Terns Pharmaceuticals fundamentals over time.
As of today, The relative strength index (RSI) of Terns Pharmaceuticals' share price is at 54. This usually implies that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Terns Pharmaceuticals, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.30) | EPS Estimate Current Year (1.09) | EPS Estimate Next Year (1.22) | Wall Street Target Price 53.5556 | EPS Estimate Current Quarter (0.30) |
Using Terns Pharmaceuticals hype-based prediction, you can estimate the value of Terns Pharmaceuticals from the perspective of Terns Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Terns Pharmaceuticals using Terns Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Terns using crowd psychology based on the activity and movement of Terns Pharmaceuticals' stock price.
Terns Pharmaceuticals Short Interest
An investor who is long Terns Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Terns Pharmaceuticals and may potentially protect profits, hedge Terns Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 10.7488 | Short Percent 0.1174 | Short Ratio 2.41 | Shares Short Prior Month 8.8 M | 50 Day MA 27.9034 |
Terns Pharmaceuticals Hype to Price Pattern
Investor biases related to Terns Pharmaceuticals' public news can be used to forecast risks associated with an investment in Terns. The trend in average sentiment can be used to explain how an investor holding Terns can time the market purely based on public headlines and social activities around Terns Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Terns Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Terns Pharmaceuticals.
Terns Pharmaceuticals Implied Volatility | 0.94 |
Terns Pharmaceuticals' implied volatility exposes the market's sentiment of Terns Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Terns Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Terns Pharmaceuticals stock will not fluctuate a lot when Terns Pharmaceuticals' options are near their expiration.
The Triple Exponential Smoothing forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 39.43 with a mean absolute deviation of 1.14 and the sum of the absolute errors of 68.15. Terns Pharmaceuticals after-hype prediction price | USD 39.19 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections. Open Interest Against 2026-03-20 Terns Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Terns Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Terns Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Terns Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Terns Pharmaceuticals' open interest, investors have to compare it to Terns Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Terns Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Terns. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Terns Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Terns price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Terns using various technical indicators. When you analyze Terns charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Terns Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 7th of January
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 39.43 with a mean absolute deviation of 1.14, mean absolute percentage error of 3.73, and the sum of the absolute errors of 68.15.Please note that although there have been many attempts to predict Terns Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Terns Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Terns Pharmaceuticals Stock Forecast Pattern
| Backtest Terns Pharmaceuticals | Terns Pharmaceuticals Price Prediction | Buy or Sell Advice |
Terns Pharmaceuticals Forecasted Value
In the context of forecasting Terns Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Terns Pharmaceuticals' downside and upside margins for the forecasting period are 28.33 and 50.53, respectively. We have considered Terns Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Terns Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Terns Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.2715 |
| MAD | Mean absolute deviation | 1.1358 |
| MAPE | Mean absolute percentage error | 0.0476 |
| SAE | Sum of the absolute errors | 68.15 |
Predictive Modules for Terns Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Terns Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Terns Pharmaceuticals
For every potential investor in Terns, whether a beginner or expert, Terns Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Terns Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Terns. Basic forecasting techniques help filter out the noise by identifying Terns Pharmaceuticals' price trends.Terns Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Terns Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Terns Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Terns Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Terns Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Terns Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Terns Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Terns Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Terns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Terns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Terns Pharmaceuticals stock market strength indicators, traders can identify Terns Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 155549.0 | |||
| Daily Balance Of Power | (0.36) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 39.21 | |||
| Day Typical Price | 39.2 | |||
| Price Action Indicator | (0.48) | |||
| Period Momentum Indicator | (0.92) | |||
| Relative Strength Index | 54.49 |
Terns Pharmaceuticals Risk Indicators
The analysis of Terns Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Terns Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting terns stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.46 | |||
| Semi Deviation | 2.48 | |||
| Standard Deviation | 10.71 | |||
| Variance | 114.75 | |||
| Downside Variance | 13.66 | |||
| Semi Variance | 6.16 | |||
| Expected Short fall | (6.93) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Terns Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Terns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Terns Stock
| 0.88 | VTRS | Viatris | PairCorr |
| 0.81 | TLRY | Tilray Inc Earnings Call This Week | PairCorr |
| 0.87 | AZN | AstraZeneca PLC ADR | PairCorr |
Moving against Terns Stock
| 0.67 | 000813 | Dezhan HealthCare | PairCorr |
| 0.56 | SNY | Sanofi ADR | PairCorr |
| 0.54 | NVO | Novo Nordisk AS Aggressive Push | PairCorr |
| 0.5 | ACB | Aurora Cannabis | PairCorr |
The ability to find closely correlated positions to Terns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Terns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Terns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Terns Pharmaceuticals to buy it.
The correlation of Terns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Terns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Terns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Terns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.